Medical trials are currently being conducted at Alivation—this is your chance to help science and medicine. Study-related exams, tests, and medication will be provided at no cost, and you may be compensated for your time.

Review the open research studies below and apply for the one(s) you qualify for by filling out Join a Study Form. Check out our list of studies or contact us with any questions. Participation in all research is voluntary and not everyone may qualify. If you are interested in learning how you can assist in scientific research, or if you’d like to participate in a study for a condition not listed, please call 402.476.6060, option 4.

If you would like to submit research study ideas, or if you have any questions about studies, please send an email to research@alivation.com. 

Current Psychiatric Research Studies:

Diagnosed with ADHD or currently experiencing symptoms of ADHD.

Willing to play a digital therapeutic video game throughout the week.

  • Phase 2b study evaluating the safety and efficacy of an investigational medication for patients with Post-Traumatic Stress Disorder (PTSD)
  • The duration of the study is 16 weeks, consisting of 6 visits to the clinic
  • Must be currently experiencing symptoms of PTSD
  • The traumatic event that led to symptoms of PTSD must have occurred after the age of 17 years.
  • Compensation for your time and travel is offered
  • Study evaluating the safety and effectiveness of VNS as an adjunctive therapy for adults with treatment-resistant depression
  • The duration of the study is 64 months, consisting of 25 visits to the clinic
  • Must be currently diagnosed with Major Depressive Disorder or Bipolar Disorder and currently in a depressed mood
  • Must have tried and failed 4 treatments for depression
  • Compensation for your time and travel is offered
  • Phase 2 study evaluating a medication in obese adult patients with Schizophrenia taking an antipsychotic medication
  • The duration of the study is 30 weeks, consisting of 11 visits to the site
  • Must have a diagnosis of Schizophrenia and is currently taking an antipsychotic which has caused weight gain
  • Compensation for your time and travel is offered
  1.     Diagnosed with ADHD or currently experiencing symptoms of ADHD.
  2.     Willing to play a digital therapeutic video game throughout the week.
  • Phase 4 study evaluating the viloxazine extended-release administered with a psychostimulant in children and adolescents ages 6 to 17 with Attention-Deficit Hyperactivity Disorder (ADHD)
  • The duration of the study is 13 weeks, consisting of 11 visits to the clinic
  • Must be currently experiencing symptoms of ADHD and on a psychostimulant
  • Compensation for your time and travel is offered
  • Must be currently experiencing 1 to 6 moderate to severe migraine attacks per month
  • Compensation for your time and travel is offered
  • Phase 3 study evaluating an investigational medication for patients diagnosed with Autism Spectrum Disorder and experiences irritability associated with it.
  • The duration of the study is 13 weeks with 4 visits to the office and 5 virtual/remote visits. There is an open-label extension study after this initial study.
  • Must be currently diagnosed with Autism Spectrum Disorder and currently experiencing irritability
  • Compensation for your time and travel is offered

  • Phase 2 study evaluating an investigational medication as an adjunct therapy for patients diagnosed with Major Depressive Disorder or who have been experiencing symptoms of depression for at least 12 weeks.
  • Duration of the study is 6-8 weeks, consisting of 8 visits to the clinic
  • Must be currently experiencing moderate to severe symptoms of depression
  • Must have had an unsatisfactory response to at least 2 antidepressants during the current depressive episode
  • Compensation for your time and travel is offered

  • Phase 3 study evaluating an investigational medication as an adjunct therapy for patients diagnosed with Major Depressive Disorder and experience insomnia or trouble sleeping
  • The duration of the study is 13 weeks, consisting of 13 visits to the clinic
  • Must be currently experiencing moderate to severe symptoms of depression
  • Must have had an unsatisfactory response to at least 1 antidepressant, but no more than 2 antidepressants, during the current depressive episode
  • Compensation for your time and travel is offered

  • Phase 3 study evaluating an investigational medication plus an adjunctive antidepressant for patients diagnosed with Major Depressive Disorder or who have been experiencing symptoms of depression at least 4 weeks.
  • The duration of the study is 8 weeks, consisting of 11 visits to the clinic
  • Must be currently experiencing moderate to severe symptoms of depression
  • Must be willing to delay the start of any medication for depression (other than the study medication and an antidepressant)
  • Compensation for your time and travel is offered

  • Phase 2 study evaluating the safety and efficacy of cariprazine as an adjunct to an antidepressant in the treatment of patients with a generalized anxiety disorder (GAD)
  • The duration of the study is 10 weeks, consisting of 7 visits to the clinic
  • Must be currently experiencing symptoms of anxiety and currently on an antidepressant approved for anxiety
  • Compensation for your time and travel is offered
Current Primary Care Research Studies:
Upcoming Psychiatric Research Studies:

More details on this study are coming soon.

More details on this study are coming soon.

More details on this study are coming soon.

More details on this study are coming soon.

Upcoming Primary Care Research Studies:

Our dedicated research staff is certified to conduct clinical trials according to Good Clinical Practices (GCP), adhering to all written standard operating procedures (SOPs) and HIPPA regulations.